首页> 美国卫生研究院文献>Hereditary Cancer in Clinical Practice >Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing
【2h】

Large family with both parents affected by distinct BRCA1 mutations: implications for genetic testing

机译:父母双双受明显BRCA1突变影响的大家庭:对基因检测的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although the probability of both parents being affected by BRCA1 mutations is not negligible, such families have not been systematically described in the literature. Here we present a large breast-ovarian cancer family, where 3 sisters and 1 half-sister inherited maternal BRCA1 5382insC mutation while the remaining 2 sisters carried paternal BRCA1 1629delC allele. No BRCA1 homozygous mutations has been detected, that is consistent with the data on lethality of BRCA1 knockout mice. This report exemplifies that the identification of a single cancer-predisposing mutation within the index patient may not be sufficient in some circumstances. Ideally, all family members affected by breast or ovarian tumor disease have to be subjected to the DNA testing, and failure to detect the mutation in any of them calls for the search of the second cancer-associated allele.
机译:尽管父母双方受BRCA1突变影响的可能性均不可忽略,但文献中并未系统地描述此类家庭。在这里,我们介绍了一个大型的乳腺癌卵巢癌家族,其中3个姐妹和1个半姐妹继承了母体BRCA1 5382insC突变,而其余2个姐妹携带了母体BRCA1 1629delC等位基因。没有检测到BRCA1纯合突变,这与BRCA1基因敲除小鼠的致死率数据一致。该报告举例说明,在某些情况下,识别索引患者中单个易患癌症的突变可能还不够。理想情况下,所有受乳腺或卵巢肿瘤疾病影响的家庭成员都必须接受DNA测试,而未能检测到任何一个人的突变都需要寻找第二个与癌症相关的等位基因。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号